Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are on the front lines in the battle against unknown diseases with the JLABS/BARDA Blue Knight program. Seth Salpeter, Co-Founder and CEO of Immunyx Pharma guests on BioTalk with Rich Bendis
Bill Hearl, Ph.D., Immunomic Therapeutics (EP.54)
Sean Kirk, Emergent BioSolutions (EP.53)
Stewart Edelstein, Universities at Shady Grove (EP.52)
Chris Frew, BioBuzz and Workforce Genetics (EP.51)
Judy Costello, BioHealth Innovation (EP.50)
Pete Briskman, JLL (EP.49)
Andrea Alms, BioHealth Capital Fund (EP.48)
Chuck Morton, Venable, LLP (EP.47)
Christian Barrow, JPMorgan Chase (EP.46)
Michael Lenardo, M.D., National Institutes of Health (NIH) NIAID/DIR (EP.45)
Dr. Faz Bashi, M.D., Super Angel Investor (EP.44)
Dr. Murat Kalayoglu, MD, Ph.D., Cartesian Therapeutics (EP.43)
Dr. Hilja Ibert, Ph.D., Gentian (EP.42)
Carolyn Yarina, Sisu Global Health (EP.41)
Sara Nayeem, M.D., NEA (EP.40)
Dr. Zan Fleming, M.D. and Thomas Seoh, Kinexum (EP.39)
Bob Kramer, Emergent BioSolutions (EP.38)
Dr. Ethel Rubin, BioHealth Innovation’s Entrepreneur-In-Residence (EP.37)
Doug Doerfler, MaxCyte (EP.36)
Dr. Amrie Grammer, AMPEL BioSolutions (EP.35)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money